|
GB202020736D0
|
|
Methods for improving mitophagy in subjects
|
|
GB202020499D0
|
|
Urolithin uses
|
|
GB202001328D0
|
|
Combination
|
|
GB201916046D0
|
|
Diagnostic method
|
|
GB201912107D0
|
|
Combination
|
|
US2019328703A1
|
|
Urolithins as immune response enhancers
|
|
CN112074510A
|
|
Industrial-Scale Synthesis of urolithin A
|
|
GB201807819D0
|
|
Biological enhancer
|
|
GB201807051D0
|
|
Biological enhancer
|
|
US2018256471A1
|
|
Skin Treatment Methods
|
|
EP3592425A1
|
|
Methods for improving mitophagy in subjects
|
|
EP3592424A1
|
|
Methods for improving mitophagy in subjects
|
|
GB201707861D0
|
|
Methods for improving mitophagy in subjects
|
|
GB201707863D0
|
|
Methods for improving mitophagy in subjects
|
|
GB201706594D0
|
|
Methods for improving mitophagy in subjects
|
|
GB201706596D0
|
|
Methods for improving mitophagy in subjects
|
|
GB201703768D0
|
|
Skin treatment methods
|
|
GB201703735D0
|
|
Methods for improving mitophagy in subjects
|
|
GB201703734D0
|
|
Skin treatment methods
|
|
GB201703736D0
|
|
Methods for improving mitophagy in subjects
|
